Over 100M Procedures Performed with Nanosonics' trophon Devices Across North America Since 2011 Protecting Patients from Ultrasound Probe Cross-Contamination

Author's Avatar
Jun 08, 2022

Nanosonics (ASX: NAN), a leader in infection prevention solutions, today announced that patients in North America have been protected from the risk of ultrasound probe cross-contamination in over 100 million trophon® high level disinfection (HLD) procedures.